ES501195A0 - Procedimiento para la preparacion de imidosulfamidas antia- lergicas - Google Patents

Procedimiento para la preparacion de imidosulfamidas antia- lergicas

Info

Publication number
ES501195A0
ES501195A0 ES501195A ES501195A ES501195A0 ES 501195 A0 ES501195 A0 ES 501195A0 ES 501195 A ES501195 A ES 501195A ES 501195 A ES501195 A ES 501195A ES 501195 A0 ES501195 A0 ES 501195A0
Authority
ES
Spain
Prior art keywords
imidosulfamides
allergic
procedure
preparation
allergic imidosulfamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES501195A
Other languages
English (en)
Other versions
ES8207145A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of ES8207145A1 publication Critical patent/ES8207145A1/es
Publication of ES501195A0 publication Critical patent/ES501195A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ES501195A 1980-04-14 1981-04-09 Procedimiento para la preparacion de imidosulfamidas antia- lergicas Granted ES501195A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14002180A 1980-04-14 1980-04-14
US06/159,340 US4315935A (en) 1980-04-14 1980-06-13 N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolinolyl]disulfonylimides and antiallergic compositions and method of use

Publications (2)

Publication Number Publication Date
ES8207145A1 ES8207145A1 (es) 1982-09-01
ES501195A0 true ES501195A0 (es) 1982-09-01

Family

ID=26837794

Family Applications (1)

Application Number Title Priority Date Filing Date
ES501195A Granted ES501195A0 (es) 1980-04-14 1981-04-09 Procedimiento para la preparacion de imidosulfamidas antia- lergicas

Country Status (25)

Country Link
US (1) US4315935A (es)
EP (1) EP0038177B1 (es)
KR (1) KR850000272B1 (es)
AR (1) AR229160A1 (es)
AU (1) AU536754B2 (es)
BG (1) BG35328A3 (es)
CA (1) CA1162545A (es)
CS (1) CS222695B2 (es)
DD (1) DD158240A5 (es)
DE (1) DE3160805D1 (es)
DK (1) DK149846C (es)
ES (1) ES501195A0 (es)
FI (1) FI74702C (es)
GR (1) GR75217B (es)
IE (1) IE51220B1 (es)
IL (1) IL62631A (es)
MX (1) MX6697E (es)
NO (1) NO811278L (es)
NZ (1) NZ196773A (es)
PL (1) PL125404B1 (es)
PT (1) PT72828B (es)
RO (1) RO81944A (es)
SU (1) SU1017169A3 (es)
YU (1) YU98081A (es)
ZW (1) ZW8381A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
US4385047A (en) * 1981-01-05 1983-05-24 Smithkline Beckman Corporation Antiallergic imidodisulfamides
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
US4350698A (en) * 1981-09-25 1982-09-21 Smithkline Corporation Antiallergic imidosulfamides
US4536510A (en) * 1983-07-22 1985-08-20 Smith Kline Beckman Corporation Method of antagonizing the effects of thromboxane
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
AU2001256733A1 (en) * 2000-05-16 2001-11-26 Takeda Chemical Industries Ltd. Melanin-concentrating hormone antagonist
JP2009504790A (ja) * 2005-08-22 2009-02-05 トランスファート プラス エスイーシー スルホニルイミド及びその誘導体を調製するための方法
JP5630048B2 (ja) 2009-03-31 2014-11-26 セントラル硝子株式会社 イミド酸化合物の製造方法
JP5471045B2 (ja) 2009-06-03 2014-04-16 セントラル硝子株式会社 イミド酸塩の製造方法
AR080375A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida
WO2012124744A1 (ja) 2011-03-14 2012-09-20 大正製薬株式会社 含窒素縮合複素環化合物
CN103524387A (zh) * 2013-10-25 2014-01-22 中国海洋石油总公司 一种双氟磺酰亚胺锂盐的制备方法
CN109721037B (zh) 2019-03-11 2019-12-24 上海如鲲新材料有限公司 一种双氟磺酰亚胺盐的新工艺
CN115010102B (zh) * 2022-06-29 2024-01-26 山东凯盛新材料股份有限公司 一种双氟磺酰亚胺的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
AT352135B (de) * 1975-07-30 1979-09-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer homophthalimide und ihrer salze
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
US4252818A (en) * 1979-08-02 1981-02-24 Merck & Co., Inc. Novel benzopyran derivatives

Also Published As

Publication number Publication date
DK149846B (da) 1986-10-13
NZ196773A (en) 1983-07-15
SU1017169A3 (ru) 1983-05-07
US4315935A (en) 1982-02-16
AR229160A1 (es) 1983-06-30
PL230622A1 (es) 1981-12-23
FI74702B (fi) 1987-11-30
IE810829L (en) 1981-10-14
PT72828A (en) 1981-05-01
MX6697E (es) 1985-10-21
NO811278L (no) 1981-10-15
PL125404B1 (en) 1983-05-31
DK160681A (da) 1981-10-15
IL62631A (en) 1984-05-31
EP0038177B1 (en) 1983-08-31
FI811082L (fi) 1981-10-15
DK149846C (da) 1987-06-29
PT72828B (en) 1982-03-30
GR75217B (es) 1984-07-13
AU6920081A (en) 1981-10-22
BG35328A3 (en) 1984-03-15
ES8207145A1 (es) 1982-09-01
DE3160805D1 (en) 1983-10-06
KR850000272B1 (ko) 1985-03-15
RO81944A (ro) 1983-06-01
EP0038177A1 (en) 1981-10-21
DD158240A5 (de) 1983-01-05
CA1162545A (en) 1984-02-21
YU98081A (en) 1983-10-31
RO81944B (ro) 1983-05-30
KR830005148A (ko) 1983-08-03
ZW8381A1 (en) 1981-07-08
CS222695B2 (en) 1983-07-29
IE51220B1 (en) 1986-11-12
FI74702C (fi) 1988-03-10
AU536754B2 (en) 1984-05-24

Similar Documents

Publication Publication Date Title
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
ES501195A0 (es) Procedimiento para la preparacion de imidosulfamidas antia- lergicas
MX6802E (es) Procedimiento para la preparacion de derivados carboestirilicos
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
AR231288A1 (es) Procedimiento para la preparacion de 3-amido-n-/2-5-dimetilaminometil-furan-2-il-metiltio etil-benzamidas
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES501535A0 (es) Procedimiento para la preparacion de derivados de alquilfos-fonito
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES499729A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol
ES503407A0 (es) Procedimiento para la preparacion de derivados de pirimidina
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES501736A0 (es) Procedimiento para la preparacion de derivados de 2-guanidi-notiazol
AR225813A1 (es) Procedimiento para la preparacion de 3-picolina
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES505576A0 (es) Procedimiento para la preparacion de derivados de 7-oxopros-taciclina
AR229890A1 (es) Procedimiento para la preparacion de 1-carvona
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
ES499356A0 (es) Procedimiento para la preparacion de derivados de rifamicina
ES505324A0 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas
ES499209A0 (es) Procedimiento para la preparacion de 3-desoxi-a15-esteroides
ES505037A0 (es) Procedimiento para la preparacion de derivados de aminotio- les